| Product Name | MF | CAS | Details |
|---|
| CYCLOHEXYL N-(M-ANISYL)CARBAMATE | 200058-20-4 | Details |
| 2-(P-TOLYLTHIO)-ETHANOL | C9H12OS | 13290-16-9 | Details |
| 4-((3-METHYLBENZYLIDENE)AMINO)-5-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL | C17H16N4S | 613230-67-4 | Details |
| 5-(4-HYDROXY-3-METHOXYBENZYLIDENE)BARBITURIC ACID | C12H10N2O5 | 40367-32-6 | Details |
| Anti-TFIP8 antibody produced in rabbit | Details |
| 4'-[(PHENYLSULFONYL)OXY][1,1'-BIPHENYL]-4-YL BENZENESULFONATE | C24H18O6S2 | 300406-03-5 | Details |
| 3-CHLORO-N-[2-((2E)-2-{4-[(4-CHLOROBENZYL)OXY]-3-METHOXYBENZYLIDENE}HYDRAZINO)-2-OXOETHYL]BENZAMIDE | C24H21Cl2N3O4 | 881448-88-0 | Details |
| Cholenic acid | C24H38O3 | 5255-17-4 | Details |
| 4-Ethynylbenzonitrile | C9H5N | 3032-92-6 | Details |
| 4-AZATRICYCLO[3.3.2.0(2,8)]DECA-3,6,9-TRIEN-3-YL ETHYL ETHER | C11H13NO | 19313-04-3 | Details |
| 4-BR-2-(2-((4-ETHOXYANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 4-CHLOROBENZOATE | C24H19BrClN3O5 | 765911-01-1 | Details |
| BICYCLO[2.2.1]HEPTA-2,5-DIENE-2,3-DICARBONITRILE | C9H6N2 | 825-24-1 | Details |
| (4-CHLORO-2-OXO-BENZOTHIAZOL-3-YL)-ACETIC ACID 4-ALLYL-2-METHOXY-PHENYL ESTER | 154184-41-5 | Details |
| N-(2-BENZYLPHENYL)-2-(4-OXO-3(4H)-QUINAZOLINYL)ACETAMIDE | C23H19N3O2 | 853318-99-7 | Details |
| Acridine orange zinc chloride double salt (C.I.46005) | C17H20Cl3N3Zn | 10127-02-3 | Details |
| 6,7-DICHLORO-3-(3,5-DICHLOROPHENYL)-1,2,4-BENZOTRIAZIN-4(1H)-OL | C13H7Cl4N3O | 868260-14-4 | Details |
| N-(3-CHLOROPHENYL)-6-[(5E)-4-OXO-5-(2-THIENYLMETHYLENE)-2-THIOXO-1,3-THIAZOLIDIN-3-YL]HEXANAMIDE | C20H19ClN2O2S3 | 613224-52-5 | Details |
| 3-BENZYL-4-METHYL-7-((2-METHYL-2-PROPENYL)OXY)-2H-CHROMEN-2-ONE | C21H20O3 | 374709-28-1 | Details |
| 2-(4-CHLORO-PHENYL)-QUINOLINE-4-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDE | 507258-70-0 | Details |
| 1-ACETYL-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE | C14H17NO | 5855-23-2 | Details |
| CF 594 succinimidyl ester | Details |
| 1-(2-(3,4-DICHLOROBENZOYL)CARBOHYDRAZONOYL)-2-NAPHTHYL 3-METHYLBENZOATE | C26H18Cl2N2O3 | 880057-10-3 | Details |
| 1-Naphthyl diphenylsulfonium triflate | C23H17F3O3S2 | 116808-69-6 | Details |
| 4-AMINO-N-(6-BROMO-2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)BENZENESULFONAMIDE | C14H13BrN4O2S | 957759-89-6 | Details |
| 2-CHLORO-N-(4-PHENOXYPHENYL)ACETAMIDE | C14H12ClNO2 | 36160-84-6 | Details |
| 1-BUTYL-4-HYDROXY-N-(3-METHYLPHENYL)-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBOXAMIDE | C21H22N2O3 | 300716-15-8 | Details |
| N-(1-BENZYL-2-PHENYLETHYL)-4-METHYLBENZENESULFONAMIDE | C22H23NO2S | 859492-81-2 | Details |
| LightOx72 | Details |
| Desiccant Cartridge | Details |
| 4-BROMO-2-(2-(4-((4-METHYLBENZYL)OXY)BENZOYL)CARBOHYDRAZONOYL)PHENYL 4-METHYLBENZOATE | C30H26BrN2O4 | 881461-05-8 | Details |
| Anti-SPCS3 antibody produced in rabbit | Details |
| 1-(2-(2,4-DICHLOROBENZOYL)CARBOHYDRAZONOYL)-2-NAPHTHYL 2-CHLOROBENZOATE | C25H15Cl3N2O3 | 880065-34-9 | Details |
| Triflupromazine hydrochloride | C18H20ClF3N2S | 1098-60-8 | Details |
| 1-(1-ADAMANTYLCARBONYL)-4-((4-BROMOPHENYL)THIO)-3,5-DIMETHYL-1H-PYRAZOLE | C22H25BrN2OS | 394237-28-6 | Details |
| (1Z)-3-METHOXY-1-[(4-NITROBENZOYL)AMINO]-3-OXO-2-(TRIPHENYLPHOSPHONIO)-1-PROPENE-1-THIOLATE | 463928-81-6 | Details |
| PrEST Antigen TRAF3IP2 | Details |
| Anti-MANBAL antibody produced in rabbit | Details |
| 2-{[5-(4-BROMOPHENYL)-4-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N'-[(E)-(5-METHYL-2-THIENYL)METHYLIDENE]ACETOHYDRAZIDE | C22H18BrN5OS2 | 306753-36-6 | Details |
| 18:0 PC-d74 | C44H88NO8P | 326495-38-9 | Details |
| Anti-TNNI2 antibody produced in rabbit | Details |
| 2-(2,4-DICHLOROPHENOXY)-N'-(4-METHYLCYCLOHEXYLIDENE)ACETOHYDRAZIDE | C15H18Cl2N2O2 | 303087-41-4 | Details |
| 3-{[(2-phenylethyl)amino]methyl}-2,3-dihydro-4H-chromen-4-one hydrochloride | Details |
| N-(2,4-DICHLORO-PHENYL)-3,5-DINITRO-BENZAMIDE | C13H7Cl2N3O5 | 36293-36-4 | Details |
| 4-BROMO-2-(2-ISONICOTINOYLCARBOHYDRAZONOYL)PHENYL 3-PHENYLACRYLATE | C22H16BrN3O3 | 880035-69-8 | Details |
| 1,3,6-Trichloroisoquinoline | C9H4Cl3N | 1053658-49-3 | Details |
| 4-Bromo-1H-pyrazole-3-carbonitrile | C4H2BrN3 | 288246-16-2 | Details |
| Anti-NOP16 antibody produced in rabbit | Details |
| 1-NITRO-3-[2,2,2-TRICHLORO-1-(3-NITROPHENYL)ETHYL]BENZENE | C14H9Cl3N2O4 | 167284-99-3 | Details |
| 2-(4-(2,4-DINITROPHENYLAZO)-N-ETHYLANILINO)-1-ETHANOL | C16H17N5O5 | 62570-20-1 | Details |
| Anti-FGF-2/basic FGF (neutralizing) Antibody, clone bFM-1 | Details |
| 3,3'-DINITRO-2,2',5,5',6,6'-HEXAMETHOXYBIPHENYL | 198993-06-5 | Details |
| 4-(2-(((4-ETHOXYBENZOYL)AMINO)ACETYL)CARBOHYDRAZONOYL)PHENYL 4-PROPOXYBENZOATE | C28H29N3O6 | 765275-54-5 | Details |
| 2-(2-(4-FLUOROBENZYLIDENE)HYDRAZINO)-N-(4-METHOXYPHENYL)-2-OXOACETAMIDE | C16H14FN3O3 | 357267-59-5 | Details |
| 1-(Toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine | C14H12N2O2S | Details |
| nitro-Grela SI-o-tolyl | Details |
| (5-AMINO-1-(2-METHYLPHENYL)-1H-PYRAZOL-4-YL)(4-BROMOPHENYL)METHANONE | C17H14BrN3O | 618091-78-4 | Details |
| Anti-Sodium Channel, Pan antibody produced in rabbit | Details |
| ETHYL (2-{[(4-HYDROXY-1-ISOPENTYL-2-OXO-1,2-DIHYDRO-3-QUINOLINYL)CARBONYL]AMINO}-1,3-THIAZOL-4-YL)ACETATE | C22H25N3O5S | 334498-27-0 | Details |
| 2-Methyl-6-(methylsulfonyl)-7-(3-piperidinyl)pyrazolo[1,5-a]pyrimidine | C13H18N4O2S | 1375066-37-7 | Details |
| [3-(tetrahydro-2H-pyran-2-yloxy)androst-5-en-17-yl]methanol | C25H40O3 | 1314441-51-4 | Details |
| 3-[(Z)-(3-ETHYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-9-METHYL-2-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C20H22N4O3S2 | 381196-33-4 | Details |
| 5-CYCLOPROPYL-2H-PYRAZOLE-3-CARBOXYLIC ACID (4-NITRO-BENZYLIDENE)-HYDRAZIDE | 306302-23-8 | Details |
| Anti-GRB2 Antibody, clone 3F2 | Details |
| RCL T237736 | Details |
| 4-({(E)-[4-(BENZYLOXY)PHENYL]METHYLIDENE}AMINO)-5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL | C23H20N4OS | 478255-49-1 | Details |
| 3-(5-(2-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-2-FURYL)-2-(2-THIENYL)ACRYLONITRILE | C18H9ClF3NOS | 892148-20-8 | Details |
| METHYL 5-([(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-4-PENTENOYL]AMINO)-4-OXOPENTANOATE | C16H26N2O6 | 1217461-57-8 | Details |
| Anti-EEF1AKMT3 antibody produced in rabbit | Details |
| 18:1 PE pSar25 | 2936622-32-9 | Details |
| Anti-APP A4, a.a. 66-81 of APP {NT} Antibody, clone 22C11, Alexa Fluor 647 Conjugate | Details |
| SQPAK Care A Cleaner | Details |
| Methyl 2-hexynoate | C7H10O2 | 18937-79-6 | Details |
| 2-(((2-(3-ALLYL-2-HYDROXYBENZYLIDENE)HYDRAZINO)(OXO)AC)AMINO)-N-PHENYLBENZAMIDE | C25H22N4O4 | 880029-16-3 | Details |
| 2-(4-BENZYL-1-PIPERIDINYL)-7-METHYL-3-[(E)-(4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C25H24N4O2S2 | 500271-78-3 | Details |
| Bisdionin C | C17H20N8O4 | 74857-22-0 | Details |
| METHYL 4-((2-(2-((4-METHOXYANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENOXY)METHYL)BENZOATE | C25H23N3O6 | 881402-59-1 | Details |
| 2-{4-[3-(TRIFLUOROMETHYL)PHENYL]-1-PIPERAZINYL}ETHYL 4-(BENZYLOXY)-5,7-DICHLORO-2-QUINOLINECARBOXYLATE | 380636-09-9 | Details |
| (+)-δ-Tocopherol | C27H46O2 | 119-13-1 | Details |
| 1-(3-CHLORO-2-METHYL-PHENYL)-3-(4-FLUORO-BENZOYL)-THIOUREA | 300819-57-2 | Details |
| Anti-RACK1 (C-terminal) antibody produced in rabbit | Details |
| tert-Butyl (2R)-2-[(ethylamino)methyl]-1-pyrrolidinecarboxylate | C12H24N2O2 | 1009075-39-1 | Details |
| 2-((3-BROMOBENZYL)OXY)BENZALDEHYDE (2-NITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZONE | C21H15BrF3N3O3 | 329058-28-8 | Details |
| (2-PHENYLSULFANYL-ACETYLAMINO)-ACETIC ACID METHYL ESTER | C11H13NO3S | 330197-48-3 | Details |
| N'-[(4-METHOXYPHENYL)METHYLIDENE]-2-(5,6,7,8-TETRAHYDRO-2-NAPHTHALENYLOXY)ACETOHYDRAZIDE | C20H22N2O3 | 354547-92-5 | Details |
| Sanitary Valve Kit | Details |
| Anti-Znf474 Antibody Produced In Rabbit | Details |
| Anti-HPGD antibody produced in mouse | Details |
| 4-BROMO-2-(2-((3-METHYLPHENOXY)ACETYL)CARBOHYDRAZONOYL)PHENYL 3-PHENYLACRYLATE | C25H21BrN2O4 | 880037-75-2 | Details |
| Anti-ZNF433 antibody produced in rabbit | Details |
| 3-{(E)-[3-(4-METHYLBENZYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}-2-(1-PIPERIDINYL)-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C25H24N4O2S2 | 442868-24-8 | Details |
| N-(3-CHLOROPHENYL)-N'-(2,6-DICHLOROPHENYL)UREA | C13H9Cl3N2O | 82745-11-7 | Details |
| N-(4-(1-HO-2-(3-HO-6-NITRO-2-QUINOXALINYL)-2-((PH-AC)HYDRAZONO)ET)PH)ACETAMIDE | C26H22N6O6 | 883813-79-4 | Details |
| CI 976 | C23H39NO4 | 114289-47-3 | Details |
| Paroxetine hydrochloride hemihydrate | C19H23ClFNO4 | 110429-35-1 | Details |
| Monoclonal Anti-HLA-DPB1 antibody produced in mouse | Details |
| NADase from porcine brain | 9032-65-9 | Details |
| Human CD2 ELISA | Details |
| TOYOPEARL GigaCap? Q-650M Bulk Media | Details |
| NovAseptic? Flow Through (1/2") Valve Body 180° | Details |
| WHEATON? clear sample vial with PTFE faced rubber lined cap packed in partitioned tray | Details |
| Product Total： Product Page： | ||||
| 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 | ||||